{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T23:42:17Z","timestamp":1782776537432,"version":"3.54.5"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T00:00:00Z","timestamp":1715558400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T00:00:00Z","timestamp":1715558400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100001249","name":"University of Tasmania","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001249","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Saf"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1007\/s40264-024-01435-3","type":"journal-article","created":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T13:02:33Z","timestamp":1715605353000},"page":"771-781","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Predictors of Adverse Drug Reaction-Related Hospitalisations Among People with Dementia: A Retrospective Case-Control Study"],"prefix":"10.1007","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1293-2289","authenticated-orcid":false,"given":"Anum Saqib","family":"Zaidi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6764-3882","authenticated-orcid":false,"given":"Gregory M.","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5029-7541","authenticated-orcid":false,"given":"Colin M.","family":"Curtain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9131-7465","authenticated-orcid":false,"given":"Mohammed S.","family":"Salahudeen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,13]]},"reference":[{"issue":"9237","key":"1435_CR1","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S0140-6736(00)02799-9","volume":"356","author":"IR Edwards","year":"2000","unstructured":"Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet. 2000;356(9237):1255\u20139.","journal-title":"Lancet"},{"issue":"6","key":"1435_CR2","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1258\/jrsm.2010.100113","volume":"103","author":"TY Wu","year":"2010","unstructured":"Wu TY, Jen MH, Bottle A, Molokhia M, Aylin P, Bell D, et al. Ten-year trends in hospital admissions for adverse drug reactions in England 1999\u20132009. J R Soc Med. 2010;103(6):239\u201350.","journal-title":"J R Soc Med"},{"issue":"7","key":"1435_CR3","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s40264-017-0528-z","volume":"40","author":"N Parameswaran Nair","year":"2017","unstructured":"Parameswaran Nair N, Chalmers L, Bereznicki BJ, Curtain C, Peterson GM, Connolly M, et al. Adverse drug reaction-related hospitalizations in elderly Australians: a prospective cross-sectional study in two Tasmanian hospitals. Drug Saf. 2017;40(7):597\u2013606.","journal-title":"Drug Saf"},{"issue":"9","key":"1435_CR4","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s40264-016-0444-7","volume":"39","author":"MT Angamo","year":"2016","unstructured":"Angamo MT, Chalmers L, Curtain CM, Bereznicki LR. Adverse drug reaction related hospitalisations in developed and developing countries: a review of prevalence and contributing factors. Drug Saf. 2016;39(9):847\u201357.","journal-title":"Drug Saf"},{"key":"1435_CR5","unstructured":"Prince MJ, Wimo A, Guerchet MM, Ali GC, Wu Y-T, Prina M. World Alzheimer Report 2015-The Global Impact of Dementia: An analysis of prevalence, incidence, cost and trends. 2015."},{"key":"1435_CR6","unstructured":"Alzheimer's Research UK. Worldwide dementia cases to triple by 2050 to over 150 million people. 2022 [cited 2023 17 March]; Available from: https:\/\/www.alzheimersresearchuk.org\/worldwide-dementia-cases-to-triple-by-2050-to-over-150-million\/. Accessed 17 Mar 2023."},{"key":"1435_CR7","unstructured":"Australian Institute of Health and Welfare. Dementia in Australia. 2023 [cited 2023 17 March]; Available from: https:\/\/www.aihw.gov.au\/reports\/dementia\/dementia-in-aus\/contents\/summary. Accessed 17 Mar 2023."},{"key":"1435_CR8","unstructured":"Dementia Australia. Dementia in Australia; 2023. Available from: https:\/\/www.dementia.org.au\/sites\/default\/files\/2023-03\/Prevalence-Data-2023-Updates.pdf. Accessed 9 Dec 2023."},{"issue":"9","key":"1435_CR9","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1002\/pds.3471","volume":"22","author":"ML Laroche","year":"2013","unstructured":"Laroche ML, Perault-Pochat MC, Ingrand I, Merle L, Kreft-Jais C, Castot-Villepelet A, et al. Adverse drug reactions in patients with Alzheimer\u2019s disease and related dementia in France: a national multicentre cross-sectional study. Pharmacoepidemiol Drug Saf. 2013;22(9):952\u201360.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"4","key":"1435_CR10","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1177\/1060028020949125","volume":"55","author":"AS Zaidi","year":"2021","unstructured":"Zaidi AS, Peterson GM, Bereznicki LR, Curtain CM, Salahudeen M. Outcomes of medication misadventure among people with cognitive impairment or dementia: a systematic review and meta-analysis. Ann Pharmacother. 2021;55(4):530\u201342.","journal-title":"Ann Pharmacother"},{"issue":"10","key":"1435_CR11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0186631","volume":"12","author":"MT Angamo","year":"2017","unstructured":"Angamo MT, Curtain CM, Chalmers L, Yilma D, Bereznicki L. Predictors of adverse drug reaction-related hospitalisation in Southwest Ethiopia: a prospective cross-sectional study. PLoS ONE. 2017;12(10): e0186631.","journal-title":"PLoS ONE"},{"key":"1435_CR12","unstructured":"Australian Bureau of Statistics. Snapshot of Tasmania. 2022 [cited 2023 11 March]; Available from: https:\/\/www.abs.gov.au\/articles\/snapshot-tas-2021. Accessed 11 Mar 2023."},{"key":"1435_CR13","unstructured":"Australian Institute of Health and Welfare. Admitted patient care NMDS 2022\u201323. 2023 [cited 2023 11 March]; Available from: https:\/\/meteor.aihw.gov.au\/content\/742173. Accessed 11 Mar 2023."},{"issue":"1","key":"1435_CR14","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/jphs.12160","volume":"8","author":"JC Veeren","year":"2017","unstructured":"Veeren JC, Weiss M. Trends in emergency hospital admissions in England due to adverse drug reactions: 2008\u20132015. J Pharm Health Serv Res. 2017;8(1):5\u201311.","journal-title":"J Pharm Health Serv Res"},{"issue":"2","key":"1435_CR15","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/bcp.13124","volume":"83","author":"SR Walter","year":"2017","unstructured":"Walter SR, Day RO, Gallego B, Westbrook JI. The impact of serious adverse drug reactions: a population-based study of a decade of hospital admissions in New South Wales, Australia. Br J Clin Pharmacol. 2017;83(2):416\u201326.","journal-title":"Br J Clin Pharmacol"},{"key":"1435_CR16","doi-asserted-by":"crossref","unstructured":"Du W, Pearson SA, Buckley NA, Day C, Banks E. Diagnosis-based and external cause-based criteria to identify adverse drug reactions in hospital ICD-coded data: application to an Australia population-based study. Public Health Res Pract. 2017;27(2):e2721716.","DOI":"10.17061\/phrp2721716"},{"key":"1435_CR17","volume-title":"Regression models for categorical and limited dependent variables","author":"JS Long","year":"1997","unstructured":"Long JS, Long JS. Regression models for categorical and limited dependent variables. Berlin: Sage; 1997."},{"key":"1435_CR18","doi-asserted-by":"crossref","first-page":"204209862210807","DOI":"10.1177\/20420986221080796","volume":"13","author":"AS Zaidi","year":"2022","unstructured":"Zaidi AS, Peterson GM, Bereznicki LRE, Curtain CM, Salahudeen MS. Ten-year trends in adverse drug reaction-related hospitalizations among people with dementia. Ther Adv Drug Saf. 2022;13:20420986221080796.","journal-title":"Ther Adv Drug Saf."},{"key":"1435_CR19","unstructured":"CalculatorSoup\u00ae. Random Number Generator. 2023 [cited 2023 3 April]; Available from: https:\/\/www.calculatorsoup.com\/calculators\/statistics\/random-number-generator.php. Accessed 3 Apr 2023."},{"issue":"1","key":"1435_CR20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2202\/1557-4679.1127","volume":"5","author":"S Rose","year":"2009","unstructured":"Rose S, Laan MJ. Why match? Investigating matched case-control study designs with causal effect estimation. Int J Biostat. 2009;5(1):1.","journal-title":"Int J Biostat"},{"issue":"14","key":"1435_CR21","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1001\/archinte.1997.00440350031003","volume":"157","author":"MH Beers","year":"1997","unstructured":"Beers MH. Explicit criteria for determining potentially inappropriate medication use by the elderly. An update Arch Intern Med. 1997;157(14):1531\u20136.","journal-title":"An update. Arch Intern Med."},{"issue":"4","key":"1435_CR22","first-page":"600","volume":"46","author":"AH Lavan","year":"2017","unstructured":"Lavan AH, Gallagher P, Parsons C, O\u2019Mahony D. STOPPFrail (Screening Tool of Older Persons Prescriptions in Frail adults with limited life expectancy): consensus validation. Age Ageing. 2017;46(4):600\u20137.","journal-title":"Age Ageing"},{"issue":"1","key":"1435_CR23","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12877-015-0029-9","volume":"15","author":"MS Salahudeen","year":"2015","unstructured":"Salahudeen MS, Duffull SB, Nishtala PS. Anticholinergic burden quantified by anticholinergic risk scales and adverse outcomes in older people: a systematic review. BMC Geriatr. 2015;15(1):31.","journal-title":"BMC Geriatr"},{"issue":"S1","key":"1435_CR24","first-page":"S142","volume":"61","author":"NL Campbell","year":"2013","unstructured":"Campbell NL, Maidment I, Fox C, Khan B, Boustani M. The 2012 Update to the Anticholinergic Cognitive Burden Scale. J Am Geriatr Soc. 2013;61(S1):S142\u20133.","journal-title":"J Am Geriatr Soc"},{"issue":"4","key":"1435_CR25","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1471-2407-4-94","volume":"20","author":"WH Hall","year":"2004","unstructured":"Hall WH, Ramachandran R, Narayan S, Jani AB, Vijayakumar S. An electronic application for rapidly calculating Charlson comorbidity score. BMC Cancer. 2004;20(4):94.","journal-title":"BMC Cancer"},{"key":"1435_CR26","unstructured":"Glover JD, Tennant SK. Remote areas statistical geography in Australia: notes on the Accessibility\/Remoteness Index for Australia (ARIA+ version): Public Health Information Development Unit, the University of Adelaide; 2003."},{"key":"1435_CR27","unstructured":"The University of Sydney. Aria lookup tool. 2023 [cited 2023 9 March]; Available from: https:\/\/www.pocog.org.au\/aria\/default.aspx. Accessed 9 Mar 2023."},{"key":"1435_CR28","unstructured":"The University of Adelaide. ARIA+ 2016 Demonstration Map. [cited 2023 11 March]; Available from: https:\/\/services.spatial.adelaide.edu.au\/giscaportal\/apps\/webappviewer\/index.html?id=417801ba9b844792af44ea4f766a3e30. Accessed 11 Mar 2023."},{"key":"1435_CR29","unstructured":"Australian Bureau of Statistics. Census of Population and Housing: Socio-Economic Indexes for Areas (SEIFA), Australia, 2016. 2018 [cited 2023 8 March]; Available from: https:\/\/www.abs.gov.au\/AUSSTATS\/abs@.nsf\/DetailsPage\/2033.0.55.0012016?OpenDocument. Accessed 8 Mar 2023."},{"issue":"8","key":"1435_CR30","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1080\/14740338.2018.1497156","volume":"17","author":"TC Eshetie","year":"2018","unstructured":"Eshetie TC, Nguyen TA, Gillam MH, Kalisch Ellett LM. A narrative review of problems with medicines use in people with dementia. Expert Opin Drug Saf. 2018;17(8):825\u201336.","journal-title":"Expert Opin Drug Saf"},{"issue":"1","key":"1435_CR31","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1177\/2042098616670798","volume":"8","author":"C Parsons","year":"2017","unstructured":"Parsons C. Polypharmacy and inappropriate medication use in patients with dementia: an underresearched problem. Ther Adv Drug Saf. 2017;8(1):31\u201346.","journal-title":"Ther Adv Drug Saf."},{"issue":"12","key":"1435_CR32","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1002\/gps.4163","volume":"29","author":"D Bishara","year":"2014","unstructured":"Bishara D, Harwood D. Safe prescribing of physical health medication in patients with dementia. Int J Geriatr Psychiatry. 2014;29(12):1230\u201341.","journal-title":"Int J Geriatr Psychiatry"},{"issue":"4","key":"1435_CR33","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1111\/j.1365-2125.2012.04423.x","volume":"75","author":"A Rollin-Sillaire","year":"2013","unstructured":"Rollin-Sillaire A, Breuilh L, Salleron J, Bombois S, Cassagnaud P, Deramecourt V, et al. Reasons that prevent the inclusion of Alzheimer\u2019s disease patients in clinical trials. Br J Clin Pharmacol. 2013;75(4):1089\u201397.","journal-title":"Br J Clin Pharmacol"},{"key":"1435_CR34","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s00228-015-1974-0","volume":"72","author":"C Pedr\u00f3s","year":"2016","unstructured":"Pedr\u00f3s C, Formiga F, Corbella X, Arnau JM. Adverse drug reactions leading to urgent hospital admission in an elderly population: prevalence and main features. Eur J Clin Pharmacol. 2016;72:219\u201326.","journal-title":"Eur J Clin Pharmacol"},{"issue":"2","key":"1435_CR35","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1080\/14740338.2018.1415322","volume":"17","author":"S Schmiedl","year":"2018","unstructured":"Schmiedl S, Rottenkolber M, Szymanski J, Drewelow B, Siegmund W, Hippius M, et al. Preventable ADRs leading to hospitalization\u2014results of a long-term prospective safety study with 6,427 ADR cases focusing on elderly patients. Expert Opin Drug Saf. 2018;17(2):125\u201337.","journal-title":"Expert Opin Drug Saf"},{"issue":"6","key":"1435_CR36","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1093\/ageing\/afaa188","volume":"49","author":"EL Jennings","year":"2020","unstructured":"Jennings EL, Murphy KD, Gallagher P, O\u2019Mahony D. In-hospital adverse drug reactions in older adults; prevalence, presentation and associated drugs\u2014a systematic review and meta-analysis. Age Ageing. 2020;49(6):948\u201358.","journal-title":"Age Ageing"},{"key":"1435_CR37","unstructured":"UK Renal Registry. Guidance for mental health professionals on the management of acute kidney injury; 2016. Available from: https:\/\/www.thinkkidneys.nhs.uk\/aki\/wp-content\/uploads\/sites\/2\/2018\/01\/Guidance-for-mental-health-patients-2018.pdf. Accessed 12 May 2023."},{"issue":"4","key":"1435_CR38","doi-asserted-by":"crossref","first-page":"26","DOI":"10.7748\/nop.2017.e898","volume":"29","author":"A Beales","year":"2017","unstructured":"Beales A. An innovative approach to hydration for a patient with dementia. Nurs Older People. 2017;29(4):26\u20139.","journal-title":"Nurs Older People"},{"issue":"2","key":"1435_CR39","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.cger.2011.01.003","volume":"27","author":"TW Meeks","year":"2011","unstructured":"Meeks TW, Culberson JW, Horton MS. Medications in long-term care: when less is more. Clin Geriatr Med. 2011;27(2):171\u201391.","journal-title":"Clin Geriatr Med"},{"issue":"10","key":"1435_CR40","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/01.NAJ.0000435351.53534.83","volume":"113","author":"M Matzo","year":"2013","unstructured":"Matzo M, Dawson KA. Opioid-induced neurotoxicity. Am J Nurs. 2013;113(10):51\u20136.","journal-title":"Am J Nurs"},{"issue":"11","key":"1435_CR41","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1002\/pds.4667","volume":"27","author":"N Parameswaran Nair","year":"2018","unstructured":"Parameswaran Nair N, Chalmers L, Peterson GM, Bereznicki BJ, Curtain CM, Bereznicki LR. Prospective identification versus administrative coding of adverse drug reaction-related hospitalizations in the elderly: a comparative analysis. Pharmacoepidemiol Drug Saf. 2018;27(11):1281\u20135.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1435_CR42","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2147\/DHPS.S29287","volume":"4","author":"A Conforti","year":"2012","unstructured":"Conforti A, Costantini D, Zanetti F, Moretti U, Grezzana M, Leone R. Adverse drug reactions in older patients: an Italian observational prospective hospital study. Drug Healthc Patient Saf. 2012;4:75\u201380.","journal-title":"Drug Healthc Patient Saf."},{"issue":"2","key":"1435_CR43","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/jgs.18108","volume":"71","author":"GM Ouellet","year":"2023","unstructured":"Ouellet GM, O\u2019Leary JR, Leggett CG, Skinner J, Tinetti ME, Cohen AB. Benefits and harms of oral anticoagulants for atrial fibrillation in nursing home residents with advanced dementia. J Am Geriatr Soc. 2023;71(2):561\u20138.","journal-title":"J Am Geriatr Soc"},{"issue":"3","key":"1435_CR44","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.3233\/JAD-170575","volume":"61","author":"A Subic","year":"2018","unstructured":"Subic A, Cermakova P, Religa D, Han S, von Euler M, K\u00e5reholt I, et al. Treatment of atrial fibrillation in patients with dementia: A cohort study from the Swedish Dementia Registry. J Alzheimers Dis. 2018;61(3):1119\u201328.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"1435_CR45","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.archger.2004.05.005","volume":"40","author":"F Caama\u00f1o","year":"2005","unstructured":"Caama\u00f1o F, Pedone C, Zuccal\u00e0 G, Carbonin P. Socio-demographic factors related to the prevalence of adverse drug reaction at hospital admission in an elderly population. Arch Gerontol Geriatr. 2005;40(1):45\u201352.","journal-title":"Arch Gerontol Geriatr"},{"key":"1435_CR46","unstructured":"tasmania Ph. Primary health tasmania, health needs assessment 2022\u201323 to 2024\u20132; 2022. Available from: https:\/\/www.primaryhealthtas.com.au\/wp-content\/uploads\/2023\/05\/Health-in-Tasmania-Comprehensive-Needs-Assessment-2022-25.pdf. Accessed 17 Mar 2024."},{"issue":"1","key":"1435_CR47","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1471-2318-14-19","volume":"14","author":"TJ Welsh","year":"2014","unstructured":"Welsh TJ, Gladman JR, Gordon AL. The treatment of hypertension in people with dementia: a systematic review of observational studies. BMC Geriatr. 2014;14(1):19.","journal-title":"BMC Geriatr"},{"key":"1435_CR48","doi-asserted-by":"crossref","DOI":"10.7573\/dic.212531","volume":"7","author":"C Guerrero-Garcia","year":"2018","unstructured":"Guerrero-Garcia C, Rubio-Guerra AF. Combination therapy in the treatment of hypertension. Drugs Context. 2018;7: 212531.","journal-title":"Drugs Context."},{"issue":"10","key":"1435_CR49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0165757","volume":"11","author":"N Parameswaran Nair","year":"2016","unstructured":"Parameswaran Nair N, Chalmers L, Connolly M, Bereznicki BJ, Peterson GM, Curtain C, et al. Prediction of hospitalization due to adverse drug reactions in elderly community-dwelling patients (the PADR-EC score). PLoS ONE. 2016;11(10): e0165757.","journal-title":"PLoS ONE"},{"issue":"2","key":"1435_CR50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0004439","volume":"4","author":"EC Davies","year":"2009","unstructured":"Davies EC, Green CF, Taylor S, Williamson PR, Mottram DR, Pirmohamed M. Adverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodes. PLoS ONE. 2009;4(2): e4439.","journal-title":"PLoS ONE"},{"issue":"7","key":"1435_CR51","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-055551","volume":"12","author":"R Osanlou","year":"2022","unstructured":"Osanlou R, Walker L, Hughes DA, Burnside G, Pirmohamed M. Adverse drug reactions, multimorbidity and polypharmacy: a prospective analysis of 1 month of medical admissions. BMJ Open. 2022;12(7): e055551.","journal-title":"BMJ Open"},{"issue":"3","key":"1435_CR52","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s41999-021-00481-9","volume":"12","author":"MB Zazzara","year":"2021","unstructured":"Zazzara MB, Palmer K, Vetrano DL, Carfi A, Onder G. Adverse drug reactions in older adults: a narrative review of the literature. Eur Geriatr Med. 2021;12(3):463\u201373.","journal-title":"Eur Geriatr Med."},{"issue":"1","key":"1435_CR53","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1186\/s12877-021-02246-2","volume":"21","author":"SC Trenaman","year":"2021","unstructured":"Trenaman SC, Bowles SK, Kirkland S, Andrew MK. An examination of three prescribing cascades in a cohort of older adults with dementia. BMC Geriatr. 2021;21(1):297.","journal-title":"BMC Geriatr"},{"issue":"1","key":"1435_CR54","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s40360-017-0157-2","volume":"18","author":"B Pfister","year":"2017","unstructured":"Pfister B, Jonsson J, Gustafsson M. Drug-related problems and medication reviews among old people with dementia. Bmc Pharmacol Toxico. 2017;18(1):52.","journal-title":"Bmc Pharmacol Toxico"},{"issue":"11","key":"1435_CR55","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1080\/17512433.2021.1961576","volume":"14","author":"MJ Sawan","year":"2021","unstructured":"Sawan MJ, Moga DC, Ma MJ, Ng JC, Johnell K, Gnjidic D. The value of deprescribing in older adults with dementia: a narrative review. Expert Rev Clin Pharmacol. 2021;14(11):1367\u201382.","journal-title":"Expert Rev Clin Pharmacol"},{"key":"1435_CR56","doi-asserted-by":"crossref","unstructured":"Varallo FR, Capucho HC, Planeta CdS, Mastroianni PdC. Safety assessment of potentially inappropriate medications (PIM) use in older people and the factors associated with hospital admission. J Pharm Pharm Sci. 2011;14(2):283\u201390.","DOI":"10.18433\/J3P01J"},{"issue":"5","key":"1435_CR57","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/pds.3592","volume":"23","author":"S Dechanont","year":"2014","unstructured":"Dechanont S, Maphanta S, Butthum B, Kongkaew C. Hospital admissions\/visits associated with drug\u2013drug interactions: a systematic review and meta-analysis. Pharmacoepidemiol Drug Saf. 2014;23(5):489\u201397.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"4","key":"1435_CR58","doi-asserted-by":"crossref","first-page":"339","DOI":"10.29252\/beat-070401","volume":"7","author":"MB Ayalew","year":"2019","unstructured":"Ayalew MB, Tegegn HG, Abdela OA. Drug related hospital admissions; a systematic review of the recent literatures. Bull Emerg Trauma. 2019;7(4):339.","journal-title":"Bull Emerg Trauma."},{"key":"1435_CR59","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/s40266-015-0310-9","volume":"32","author":"K Cardwell","year":"2015","unstructured":"Cardwell K, Hughes CM, Ryan C. The association between anticholinergic medication burden and health related outcomes in the \u2018oldest old\u2019: a systematic review of the literature. Drugs Aging. 2015;32:835\u201348.","journal-title":"Drugs Aging"},{"issue":"1","key":"1435_CR60","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1186\/1472-6963-13-473","volume":"13","author":"CM Hohl","year":"2013","unstructured":"Hohl CM, Kuramoto L, Yu E, Rogula B, Stausberg J, Sobolev B. Evaluating adverse drug event reporting in administrative data from emergency departments: a validation study. BMC Health Serv Res. 2013;13(1):473.","journal-title":"BMC Health Serv Res"}],"container-title":["Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-024-01435-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40264-024-01435-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-024-01435-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T08:35:35Z","timestamp":1722242135000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40264-024-01435-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,13]]},"references-count":60,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["1435"],"URL":"https:\/\/doi.org\/10.1007\/s40264-024-01435-3","relation":{},"ISSN":["0114-5916","1179-1942"],"issn-type":[{"value":"0114-5916","type":"print"},{"value":"1179-1942","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,13]]},"assertion":[{"value":"16 April 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors received no financial support for the research, authorship, and\/or publication of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The authors declared no potential conflicts of interest with respect to the research, authorship, and\/or publication of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}},{"value":"The study was conducted with approval from the Tasmanian Health and Medical Human Research Ethics Committee (reference number H0018582).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The data utilised in this analysis were sourced from a third party, namely the Tasmanian Department of Health and Human Services. It is important to note that these data are not publicly accessible in Australia, and the research team has not been granted permission to make them publicly available. To access the data, necessary ethics approvals must be obtained. Upon securing these approvals, the research team will be able to request access to the data in writing by contacting: The Secretary, Department of Health, GPO Box 125, Hobart, Tasmania, 7001, Australia.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of Data and Material"}},{"value":"The code of this study is available from the corresponding author upon reasonable request.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}},{"value":"Anum Saqib Zaidi: Conceptualisation; Methodology; Formal analysis; Writing \u2013 original draft. Gregory M. Peterson: Conceptualisation; Methodology; Investigation; Supervision; Visualization; Writing\u2014review & editing. Colin M. Curtain: Conceptualisation; Methodology; Investigation; Supervision; Writing\u2014review & editing. Mohammed S. Salahudeen: Conceptualisation; Methodology; Investigation; Supervision; Writing\u2014review & editing. All authors read and approved the final version.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author Contributions"}}]}}